Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study.

Individualization of treatment with peginterferon alfa and ribavirin in patients with chronic hepatitis C showed benefit in controlled trials and was implemented in treatment guidelines to increase response rates and to reduce side effects and costs. However, it is unknown whether individualization...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Wolf Peter Hofmann, Stefan Mauss, Thomas Lutz, Andreas Schober, Klaus Böker, Gero Moog, Axel Baumgarten, Heike Pfeiffer-Vornkahl, Ulrich Alshuth, Dietrich Hüppe, Heiner Wedemeyer, Michael P Manns, Eckart Schott
格式: Artigo
語言:Inglês
出版: Public Library of Science (PLoS) 2015-01-01
叢編:PLoS ONE
在線閱讀:http://europepmc.org/articles/PMC4521757?pdf=render
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍